BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 18712171)

  • 1. 10 years' experience in fragile X testing among mentally retarded individuals in Greece: a molecular and epidemiological approach.
    Sofocleous C; Kitsiou S; Fryssira H; Kolialexi A; Kalaitzidaki M; Roma E; Tsangaris GT; Chistofidou C; Metaxotou C; Kanavakis E; Mavrou A
    In Vivo; 2008; 22(4):451-5. PubMed ID: 18712171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular screening of fragile X (FRAXA) and FRAXE mental retardation syndromes in the Hellenic population of Greece and Cyprus: incidence, genetic variation, and stability.
    Patsalis PC; Sismani C; Hettinger JA; Boumba I; Georgiou I; Stylianidou G; Anastasiadou V; Koukoulli R; Pagoulatos G; Syrrou M
    Am J Med Genet; 1999 May; 84(3):184-90. PubMed ID: 10331587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fragile X mental retardation syndrome: from pathogenesis to diagnostic issues.
    Mandel JL; Biancalana V
    Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S158-65. PubMed ID: 15135801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical and molecular screening for fragile X syndrome in 300 patients with non-specific mental retardation].
    Jara L; López M; Mellado C; Aspillaga M; Avendaño I; Blanco R
    Rev Med Chil; 1998 Aug; 126(8):911-8. PubMed ID: 9830742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A genetic and molecular study of 85 families affected with the fragile X syndrome].
    Milà Recasens M; Sánchez Díaz A; Glover López G; Castellví Bel S; Carbonell Meseguer P; Kruyer H; Ballesta Martínez F; Estivill Pallejà X
    An Esp Pediatr; 1996 Mar; 44(3):250-6. PubMed ID: 8830601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [X-linked mental retardation: variations in the fragile X mutations and genetic counseling].
    Kondo I; Kurokawa Y
    Nihon Koshu Eisei Zasshi; 1993 Aug; 40(8):599-605. PubMed ID: 8219287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FRAXA and FRAXE prevalence in patients with nonspecific mental retardation in the Hellenic population.
    Syrrou M; Georgiou I; Grigoriadou M; Petersen MB; Kitsiou S; Pagoulatos G; Patsalis PC
    Genet Epidemiol; 1998; 15(1):103-9. PubMed ID: 9523214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal diagnosis and carrier screening for fragile X by PCR.
    Brown WT; Nolin S; Houck G; Ding X; Glicksman A; Li SY; Stark-Houck S; Brophy P; Duncan C; Dobkin C; Jenkins E
    Am J Med Genet; 1996 Jul; 64(1):191-5. PubMed ID: 8826474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A fragile X male with a broad smear on Southern blot analysis representing 100-500 CGG repeats and no methylation at the EagI site of the FMR-1 gene.
    Lachiewicz AM; Spiridigliozzi GA; McConkie-Rosell A; Burgess D; Feng Y; Warren ST; Tarleton J
    Am J Med Genet; 1996 Aug; 64(2):278-82. PubMed ID: 8844065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular screening for fragile X syndrome in Thailand.
    Limprasert P; Ruangdaraganon N; Sura T; Vasiknanonte P; Jinorose U
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():114-8. PubMed ID: 11400746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fragile X syndrome screening of families with consanguineous and non-consanguineous parents in the Iranian population.
    Pouya AR; Abedini SS; Mansoorian N; Behjati F; Nikzat N; Mohseni M; Nieh SE; Abbasi Moheb L; Darvish H; Monajemi GB; Banihashemi S; Kahrizi K; Ropers HH; Najmabadi H
    Eur J Med Genet; 2009; 52(4):170-3. PubMed ID: 19361583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of a clinical checklist in the diagnosis of fragile X syndrome in India.
    Guruju MR; Lavanya K; Thelma BK; Sujatha M; OmSai VR; Nagarathna V; Amarjyothi P; Jyothi A; Anandaraj MP
    J Clin Neurosci; 2009 Oct; 16(10):1305-10. PubMed ID: 19560928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [From gene to disease; fragile X-syndrome: hereditary mental retardation due to a developmental gene].
    de Vries LB; Oostra BA
    Ned Tijdschr Geneeskd; 2001 Mar; 145(10):474-6. PubMed ID: 11268909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular diagnosis and genetic counseling for fragile X mental retardation.
    Pandey UB; Phadke SR; Mittal B
    Neurol India; 2004 Mar; 52(1):36-42. PubMed ID: 15069237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A survey of fragile X syndrome in a sample from Spanish Basque country.
    Arrieta I; Criado B; Martinez B; Telez M; Nuñez T; Peñagarikano O; Ortega B; Lostao CM
    Ann Genet; 1999; 42(4):197-201. PubMed ID: 10674158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of pre-mutation of X chromosome CGG trinucleotide repeats on brain anatomy.
    Moore CJ; Daly EM; Tassone F; Tysoe C; Schmitz N; Ng V; Chitnis X; McGuire P; Suckling J; Davies KE; Hagerman RJ; Hagerman PJ; Murphy KC; Murphy DG
    Brain; 2004 Dec; 127(Pt 12):2672-81. PubMed ID: 15483045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trinucleotide CGG repeat in the FMR1 gene in Chinese mentally retarded patients.
    Pang CP; Poon PM; Chen QL; Lai KY; Yin CH; Zhao Z; Zhong N; Lau CH; Lam ST; Wong CK; Brown WT
    Am J Med Genet; 1999 May; 84(3):179-83. PubMed ID: 10331586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for high-risk haplotypes and (CGG)n expansion in fragile X syndrome in the Hellenic population of Greece and Cyprus.
    Syrrou M; Patsalis PC; Georgiou I; Hadjimarcou MI; Constantinou-Deltas CD; Pagoulatos G
    Am J Med Genet; 1996 Jul; 64(1):234-8. PubMed ID: 8826482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and instability of fragile X alleles: implications for offering fragile X prenatal diagnosis.
    Cronister A; Teicher J; Rohlfs EM; Donnenfeld A; Hallam S
    Obstet Gynecol; 2008 Mar; 111(3):596-601. PubMed ID: 18310361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA diagnosis of the fragile X syndrome in a series of 236 mentally retarded subjects and evidence for a reversal of mutation in the FMR-1 gene.
    van den Ouweland AM; de Vries BB; Bakker PL; Deelen WH; de Graaff E; van Hemel JO; Oostra BA; Niermeijer MF; Halley DJ
    Am J Med Genet; 1994 Jul; 51(4):482-5. PubMed ID: 7943024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.